US Patent 8097705 Methods and compositions for treating allergic diseases
Patent 8097705 was granted and assigned to IRM on January, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 9 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+242 characters)
Article
Patent abstract
Disclosed in the present invention are antibodies that specifically recognize and antagonize human TSLP receptor, and methods of employing these antibodies to treat or ameliorate diseases or disorder mediated by TSLP signaling.
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Liqun Dong0
Marc Nasoff0
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08097705 Methods and compositions for treating allergic diseases US Patent 8097705 Methods and compositions for treating allergic diseases
Infobox
Patent Number
080977050
Patent Number
80977050
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
080977050
Date of Patent
January 17, 2012
0Patent Application Number
121608680
Date Filed
January 11, 2007
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08097705 Methods and compositions for treating allergic diseases
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08097705
Date of patent
January 17, 2012
Patent application number
12160868
Date Filed
January 11, 2007
Patent primary examiner
Find more entities like US Patent 8097705 Methods and compositions for treating allergic diseases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
